Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Helicase Venture primarily targets early-stage investment opportunities, focusing on seed and Series A funding rounds. The firm typically commits between $1 million and $5 million in initial investments, concentrating on life sciences and computational technologies that have the potential to advance healthcare. The sectors of interest include biotech, healthcare, and artificial intelligence, with a particular emphasis on companies that are innovating in areas such as drug discovery, medical devices, and health-related technologies. Helicase Venture seeks to partner with founders who are passionate about their mission and possess a strong vision for their companies. The firm values innovative approaches that leverage engineering and AI to address significant healthcare challenges, making it an ideal partner for startups looking to make a meaningful impact in the healthcare sector.
Helicase Venture has built a notable portfolio of approximately 10 companies, showcasing its commitment to investing in transformative healthcare technologies. Among its prominent investments is **Absci**, a publicly traded company on Nasdaq that utilizes generative AI for drug creation, combining AI with wet lab biologics. Another key portfolio company is **Contineum Therapeutics** (formerly Pipeline Therapeutics), which recently secured $80 million in Series C financing to advance its neuroscience pipeline. **Ribbon Biolabs** is also part of the portfolio, recognized for its innovations in the automated synthesis of long DNA molecules. Additionally, **Medeon Biodesign** focuses on designing and manufacturing medical device solutions, while **Landos Biopharma** is developing oral therapeutics for autoimmune diseases. These investments reflect Helicase Venture's strategic focus on life sciences and its commitment to supporting companies that are poised to make significant advancements in healthcare.
To pitch Helicase Venture, send your proposal to newlp@helicaseventure.com. They prefer clear and concise pitches that outline your business model, market opportunity, and how your technology addresses significant healthcare challenges.
What stages does Helicase Venture invest in?
Helicase Venture primarily invests in early-stage companies, focusing on seed and Series A funding rounds. This allows them to support startups at critical points in their development.
How do I pitch Helicase Venture?
Founders can pitch Helicase Venture by sending an email to newlp@helicaseventure.com. It is advisable to provide a clear overview of the business model, market opportunity, and how the technology addresses significant healthcare challenges.
What sectors does Helicase Venture focus on?
Helicase Venture focuses on sectors such as biotech, healthcare, and artificial intelligence. They are particularly interested in life sciences and Bio-IT companies that are innovating to improve health outcomes.
What is Helicase Venture's typical check size?
The firm typically invests between $1 million and $5 million in its portfolio companies, providing substantial financial support to help them grow and succeed.
Where does Helicase Venture invest geographically?
Helicase Venture primarily invests in North America, concentrating on companies that are based in this region and are working to transform the healthcare landscape.
What portfolio support does Helicase Venture provide?
Helicase Venture adds value to its portfolio companies by offering strategic guidance and leveraging a wide range of scientific networks and advisors. This support is crucial for helping early-stage companies reach their full potential.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.